Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
44,538,698
-
Share change
-
+753,402
-
Total reported value
-
$4,132,289,205
-
Put/Call ratio
-
117%
-
Price per share
-
$92.91
-
Number of holders
-
334
-
Value change
-
+$74,186,002
-
Number of buys
-
158
-
Number of sells
-
179
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q1 2021
As of 31 Mar 2021,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
334 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,538,698 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Neuberger Berman Group LLC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, EARNEST PARTNERS LLC, MANUFACTURERS LIFE INSURANCE COMPANY, THE, DIMENSIONAL FUND ADVISORS LP, Invesco Ltd., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
335
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.